About Pharmaceutical Products
Filed under Pharmaceuticals
The medications or drugs, which are used in various medical treatment procedures, are commonly termed as Pharmaceuticals. These medications are usually distributed and prepared by pharmaceutical companies. Pharmaceuticals are prescribed by medical practitioners for treating both human and animals. The unbelievable development in the field of science and technology has influenced Pharmaceuticals industry immensely. Malaria, Cholera and Diphtheria that were considered as deadly or incurable diseases few decades ago, are now treated successfully with modern pharmaceutical products. Scientists are trying hard to help those patients who are suffering from lethal diseases by furthering their experimentation on various pharmaceutical products.
Extensive research and experimentation is conducted before launching a pharmaceutical product in the market. If this crucial issue is not heeded with proper care and caution, it may generate some serious repercussion in future. A patient may suffer from serious and severe side effects as well. This is the reason why the quality and affectivity of a medication needs to be ensured at any cost. A pharmaceutical product is usually tested on animals for ensuring its affectivity and safety before it is sold in the market. Without the prior permission of Food and Drug Administration, a medication cannot be sold in the market. A pharmaceutical company can hold the patent of a pharmaceutical product, if the drug is solely developed or invented by the scientists of that company.
Nowadays, pharmaceutical products have become an integral part of human life. They are bettering public health by recovering patients from the deadly clutches of lethal diseases. Pharmaceutical products are elongating the lifespan of living beings by launching new medications in the market. One can get ample information about various types of Pharmaceutical products from the official websites of different pharmaceutical companies. You will get enough information on pharmaceutical products by typing some keywords in any popular search engine.
Among different types of pharmaceutical products are available in the market, Weight Loss pharmaceutical products are seizing the attention of all. Those who are suffering from over-weight or obesity are opting for these medications to get rid of these diseases, which can disrupt the normal lifestyle of a person. Medical practitioners suggest their patients to take weight loss pills along with regular exercise and healthy diet for getting desired outcome. One can improve his/her health condition and stave off other diseases if he takes this medication on a regular basis.
If a person is got stuck with Arthritis, he should take arthritis pharmaceuticals products, which are helping patients to get relieved from the acute pain of this disease. Inflammation, soreness, discomfort etc are some of the common symptoms of arthritis, which can deter a patient from leading a normal life. In this critical situation, arthritis pharmaceuticals products can do a miraculous job.
Cancer, which is considered as a lethal disease, is still baffling scientists and medical practitioners through out the world. Calcium folinate, Carboplatin, Doxorubicin hydrochloride etc are some of the common Cancer pharmaceuticals products, which are usually prescribed by medical practitioners to reduce the severity of various symptoms of cancer.
In conclusion, one should consult with a medical practitioner before buying a pharmaceutical product from the market otherwise; he might have to brave some serious consequence in future.
By: Debdulal Das
About the Author:
Aishani is a regular writer of Pharmaceuticals Products Distributor, Play Pharma an European pharma product supplier company.
She is presently researching on pharmaceutical products.
China’s Pharmaceutical Actuality and Future
Filed under Pharmaceuticals
Only two decades ago, China was a poor agricultural country; now it becomes the third-largest economy in the world, with a GDP of more than $2, 108 billion in 2006. Experts forecast that by 2020, China will be the world’s largest economy.
1, China's pharmaceutical market
The has shown impressive growth in recent years, in tandem with the country's rapid economic expansion. In the past twenty years, China's pharmaceutical market has an averaging between 18 - 20% growth, significantly higher than US and European growth during that period (7 - 9%). The total pharmaceutical market is expected to grow to $27.7 billion by the year 2005, to become the world's largest pharmaceutical market by 2020.
2, China's pharmaceutical industry
China has a large domestic pharmaceutical industry, providing 80% of China's pharmaceutical consumption. In 1995, approximately 3,000 domestic state pharmaceutical enterprises produced a total output of $12 billion, of which more than $3 billion was exported, according to the State Pharmaceutical Administration of China (SPAC). The Chinese pharmaceutical industry has increased in value with an annual average growth rate of 16.72% over the last few decades.
However, the industry is still small-scale, with a scattered geographical layout, duplicated production processes, and outdated manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and weak international trading competitiveness, coupled with a lack of patented pharmaceuticals developed in-house.
As China joins the World Trade Organization (WTO), it needs to integrate more completely into the global economy. The international competition will place an intense pressure on the Chinese pharmaceutical industry and further open the door to a lucrative market for non-Chinese companies, especially for pharmaceutical producers and manufacturers. Accession to the WTO binds China by fundamental WTO principles, such as improved transparency and the strengthening of commercial legal procedures. China’s WTO commitments include the tightening of rules on intellectual property, tariff concessions, and market access of non-Chinese service suppliers engaging in the distribution of pharmaceuticals. All such moves create additional business opportunities for non-Chinese pharmaceutical companies in China, and in turn, place an intense pressure on the Chinese pharmaceutical industry.
So, over the past few years, Chinese pharmaceutical firms have been merging to improve economies of scale, concentrate resources, and increase competitiveness through vertical integration. Many large, state-owned pharmaceutical companies are also transforming their ownership structures into joint ventures or public companies to become more efficient. According to the SPAC, China aims to become the world’s leading producer of pharmaceuticals and medical devices and instruments in the first half of this century.
3, China's pharmaceutical foreign trade
In recent years, many Chinese pharmaceutical enterprises take part in the international pharmaceutical market. They not only export patent medicine but also assist their global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions, for example, pharmaceutical intermediate. Some Chinese pharmaceutical companies even appear in the Nasdaq market successfully, such as WuXi PharmaTech (WX.NYSE) and Simcere Pharmaceutical Group (SCR) etc.
Electronic commerce is introduced to the pharmaceutical enterprises. is one of the most famous B2B website in China. It provides various trade leads including pharmaceutical information among China factory, manufacturers, suppliers, and global buyers.
The pharmaceutical trade shows supply the platform to the leading manufacturers, suppliers and buyers both at home and abroad. Many pharmaceutical companies attend the China International Medical Equipment Fair (CMEF), China International Oral Care Technology & Equipment Exhibition and Shanghai International Medical Equipment and Furnishment Exhibition ?IMEFE? and so on. CMEF is Asia Pacific's biggest exhibition serving the entire value chain for the medical devices market. China International Oral Care Technology & Equipment Exhibition is organized by the China Oral Care Industry Association, Exhibition Center of China Light Industry. The Show covers oral care products, raw and auxiliary materials, packaging materials, manufacturing and packaging equipment, oral medical equipment and materials.
4, China's pharmaceutical market trend
First, the price of pharmaceutical products will continue to decrease steadily. In June 2004, the price of 400 antibiotics in 24 categories, including penicillin, was reduced by, on average, 35%. The total value affected by this reduction was US$42 million. The central government has been playing a significant role in pharmaceutical price readjustment. According to industry experts, future price reductions will originate from hospital pharmaceutical retail shops.
Secondly, the rural pharmaceutical market will shift significantly. According to Information Times, 80% of counterfeit products are consumed in rural areas. This provides a huge opportunity for pharmaceutical companies to develop the market in rural areas.
Thirdly, China will become the largest pharmaceutical R&D base in the world. In recent years, more and more western pharmaceutical enterprises, such as GSK, Roche, Novo Nordisk, etc, have come to China and set up R&D centers. Twenty world leading pharmaceutical companies have established joint venture manufactories in China. Some have even set up sole propriety manufactories. Currently, amongst the largest 500 overseas enterprises, 14 of them are pharmaceutical companies.
The fourth trend is that foreign enterprises will begin an OTC price war in future years. Based on expert analysis, foreign enterprises have been closely monitoring the expanding OTC market. In September 2003, German Mike Company began its OTC project in China.
By: Angulo Fu
About the Author:
1, China's pharmaceutical market
The has shown impressive growth in recent years, in tandem with the country's rapid economic expansion. In the past twenty years, China's pharmaceutical market has an averaging between 18 - 20% growth, significantly higher than US and European growth during that period (7 - 9%). The total pharmaceutical market is expected to grow to $27.7 billion by the year 2005, to become the world's largest pharmaceutical market by 2020.
2, China's pharmaceutical industry
China has a large domestic pharmaceutical industry, providing 80% of China's pharmaceutical consumption. In 1995, approximately 3,000 domestic state pharmaceutical enterprises produced a total output of $12 billion, of which more than $3 billion was exported, according to the State Pharmaceutical Administration of China (SPAC). The Chinese pharmaceutical industry has increased in value with an annual average growth rate of 16.72% over the last few decades.
However, the industry is still small-scale, with a scattered geographical layout, duplicated production processes, and outdated manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and weak international trading competitiveness, coupled with a lack of patented pharmaceuticals developed in-house.
As China joins the World Trade Organization (WTO), it needs to integrate more completely into the global economy. The international competition will place an intense pressure on the Chinese pharmaceutical industry and further open the door to a lucrative market for non-Chinese companies, especially for pharmaceutical producers and manufacturers. Accession to the WTO binds China by fundamental WTO principles, such as improved transparency and the strengthening of commercial legal procedures. China’s WTO commitments include the tightening of rules on intellectual property, tariff concessions, and market access of non-Chinese service suppliers engaging in the distribution of pharmaceuticals. All such moves create additional business opportunities for non-Chinese pharmaceutical companies in China, and in turn, place an intense pressure on the Chinese pharmaceutical industry.
So, over the past few years, Chinese pharmaceutical firms have been merging to improve economies of scale, concentrate resources, and increase competitiveness through vertical integration. Many large, state-owned pharmaceutical companies are also transforming their ownership structures into joint ventures or public companies to become more efficient. According to the SPAC, China aims to become the world’s leading producer of pharmaceuticals and medical devices and instruments in the first half of this century.
3, China's pharmaceutical foreign trade
In recent years, many Chinese pharmaceutical enterprises take part in the international pharmaceutical market. They not only export patent medicine but also assist their global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions, for example, pharmaceutical intermediate. Some Chinese pharmaceutical companies even appear in the Nasdaq market successfully, such as WuXi PharmaTech (WX.NYSE) and Simcere Pharmaceutical Group (SCR) etc.
Electronic commerce is introduced to the pharmaceutical enterprises. is one of the most famous B2B website in China. It provides various trade leads including pharmaceutical information among China factory, manufacturers, suppliers, and global buyers.
The pharmaceutical trade shows supply the platform to the leading manufacturers, suppliers and buyers both at home and abroad. Many pharmaceutical companies attend the China International Medical Equipment Fair (CMEF), China International Oral Care Technology & Equipment Exhibition and Shanghai International Medical Equipment and Furnishment Exhibition ?IMEFE? and so on. CMEF is Asia Pacific's biggest exhibition serving the entire value chain for the medical devices market. China International Oral Care Technology & Equipment Exhibition is organized by the China Oral Care Industry Association, Exhibition Center of China Light Industry. The Show covers oral care products, raw and auxiliary materials, packaging materials, manufacturing and packaging equipment, oral medical equipment and materials.
4, China's pharmaceutical market trend
First, the price of pharmaceutical products will continue to decrease steadily. In June 2004, the price of 400 antibiotics in 24 categories, including penicillin, was reduced by, on average, 35%. The total value affected by this reduction was US$42 million. The central government has been playing a significant role in pharmaceutical price readjustment. According to industry experts, future price reductions will originate from hospital pharmaceutical retail shops.
Secondly, the rural pharmaceutical market will shift significantly. According to Information Times, 80% of counterfeit products are consumed in rural areas. This provides a huge opportunity for pharmaceutical companies to develop the market in rural areas.
Thirdly, China will become the largest pharmaceutical R&D base in the world. In recent years, more and more western pharmaceutical enterprises, such as GSK, Roche, Novo Nordisk, etc, have come to China and set up R&D centers. Twenty world leading pharmaceutical companies have established joint venture manufactories in China. Some have even set up sole propriety manufactories. Currently, amongst the largest 500 overseas enterprises, 14 of them are pharmaceutical companies.
The fourth trend is that foreign enterprises will begin an OTC price war in future years. Based on expert analysis, foreign enterprises have been closely monitoring the expanding OTC market. In September 2003, German Mike Company began its OTC project in China.
By: Angulo Fu
About the Author:
A professional studies on China's import and export trade.